Twist Bioscience Corporation TWST Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's other accrued liabilities?
- Twist Bioscience Corporation (TWST) reported other accrued liabilities of $67.85M in Q1 2026.
- How has Twist Bioscience Corporation's other accrued liabilities changed year-over-year?
- Twist Bioscience Corporation's other accrued liabilities increased by 841.7% year-over-year, from $7.21M to $67.85M.
- What is the long-term trend for Twist Bioscience Corporation's other accrued liabilities?
- Over 5 years (2020 to 2025), Twist Bioscience Corporation's other accrued liabilities has grown at a 68.2% compound annual growth rate (CAGR), from $2.61M to $35.2M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.